Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gentry

Showing results (261-270 of 280) with videos related to

Pageof 28
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2008
Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in ratsAshley E Brady, Carrie K Jones, Thomas M Bridges, et al.
Circulation|January 21, 2021
Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US CohortBrandon R Allen, Robert H Christenson, Scott A Cohen, et al.
Journal of Medicinal Chemistry|November 26, 2014
Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM)Lindsey C Morris, Kellie D Nance, Patrick R Gentry, et al.
Journal of Medicinal Chemistry|October 30, 2013
Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)Patrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2012
Isatin replacements applied to the highly selective, muscarinic M1 PAM ML137: continued optimization of an MLPCN probe moleculeBruce J Melancon, Michael S Poslusney, Patrick R Gentry, et al.
ACS Chemical Neuroscience|August 5, 2021
Identification of a Novel Allosteric Site at the M<sub>5</sub> Muscarinic Acetylcholine ReceptorWessel A C Burger, Patrick R Gentry, Alice E Berizzi, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 21, 2023
A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency departmentPaula Tanabe, Stephanie Ibemere, Ava E Pierce, et al.
JAMA Cardiology|March 1, 2023
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery DiseaseNicklaus P Ashburn, Anna C Snavely, James C O'Neill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients: A Pragmatic, Randomized TrialJonathan D Baghdadi, Anthony D Harris, Lisa Pineles, et al.
Chemmedchem|April 3, 2014
Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probePatrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Pageof 28

Showing results (261-270 of 280) with videos related to

Sort By:
Pageof 28
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2008
Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in ratsAshley E Brady, Carrie K Jones, Thomas M Bridges, et al.
Circulation|January 21, 2021
Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US CohortBrandon R Allen, Robert H Christenson, Scott A Cohen, et al.
Journal of Medicinal Chemistry|November 26, 2014
Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM)Lindsey C Morris, Kellie D Nance, Patrick R Gentry, et al.
Journal of Medicinal Chemistry|October 30, 2013
Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)Patrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2012
Isatin replacements applied to the highly selective, muscarinic M1 PAM ML137: continued optimization of an MLPCN probe moleculeBruce J Melancon, Michael S Poslusney, Patrick R Gentry, et al.
ACS Chemical Neuroscience|August 5, 2021
Identification of a Novel Allosteric Site at the M<sub>5</sub> Muscarinic Acetylcholine ReceptorWessel A C Burger, Patrick R Gentry, Alice E Berizzi, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 21, 2023
A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency departmentPaula Tanabe, Stephanie Ibemere, Ava E Pierce, et al.
JAMA Cardiology|March 1, 2023
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery DiseaseNicklaus P Ashburn, Anna C Snavely, James C O'Neill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients: A Pragmatic, Randomized TrialJonathan D Baghdadi, Anthony D Harris, Lisa Pineles, et al.
Chemmedchem|April 3, 2014
Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probePatrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Pageof 28